Annual CAPEX
N/A
31 December 2023
Summary:
Akebia Therapeutics annual capital expenditures is not available.AKBA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$2000.00
-$27.00 K-93.10%
30 September 2024
Summary:
Akebia Therapeutics quarterly capital expenditures is currently $2000.00, with the most recent change of -$27.00 thousand (-93.10%) on 30 September 2024. AKBA quarterly CAPEX is now -99.92% below its all-time high of $2.53 million, reached on 30 September 2019.AKBA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$31.00 K
+$2000.00+6.90%
30 September 2024
Summary:
Akebia Therapeutics TTM capital expenditures is currently $31.00 thousand, with the most recent change of +$2000.00 (+6.90%) on 30 September 2024. AKBA TTM CAPEX is now -99.57% below its all-time high of $7.26 million, reached on 30 September 2019.AKBA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | +100.0% | -91.8% |
5 y5 years | - | -99.9% | -99.6% |
AKBA CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -98.3% | -91.8% | +6.9% | |||
5 y | 5 years | -99.9% | +104.4% | -99.6% | +6.9% | ||
alltime | all time | -99.9% | +104.4% | -99.6% | +6.9% |
Akebia Therapeutics CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2000.00(-93.1%) | $31.00 K(+6.9%) |
June 2024 | - | $29.00 K(>+9900.0%) | $29.00 K(-74.6%) |
Dec 2022 | $114.00 K(+93.2%) | $0.00(0.0%) | $114.00 K(0.0%) |
Sept 2022 | - | $0.00(0.0%) | $114.00 K(0.0%) |
June 2022 | - | $0.00(-100.0%) | $114.00 K(0.0%) |
Mar 2022 | - | $114.00 K(>+9900.0%) | $114.00 K(+93.2%) |
Dec 2021 | $59.00 K(-81.4%) | $0.00(0.0%) | $59.00 K(-84.3%) |
Sept 2021 | - | $0.00(0.0%) | $376.00 K(+13.6%) |
June 2021 | - | $0.00(-100.0%) | $331.00 K(-12.0%) |
Mar 2021 | - | $59.00 K(-81.4%) | $376.00 K(+18.6%) |
Dec 2020 | $317.00 K(-95.2%) | $317.00 K(-804.4%) | $317.00 K(+44.1%) |
Sept 2020 | - | -$45.00 K(-200.0%) | $220.00 K(-92.1%) |
June 2020 | - | $45.00 K(-79.5%) | $2.79 M(-58.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | $6.66 M(+314.4%) | $220.00 K(-91.3%) | $6.66 M(-8.4%) |
Sept 2019 | - | $2.53 M(+27.9%) | $7.26 M(+44.1%) |
June 2019 | - | $1.98 M(+2.6%) | $5.04 M(+55.7%) |
Mar 2019 | - | $1.93 M(+132.3%) | $3.24 M(+101.6%) |
Dec 2018 | $1.61 M(-1.0%) | $830.00 K(+170.4%) | $1.61 M(+31.0%) |
Sept 2018 | - | $307.00 K(+77.5%) | $1.23 M(-19.1%) |
June 2018 | - | $173.00 K(-41.6%) | $1.52 M(+1.7%) |
Mar 2018 | - | $296.00 K(-34.2%) | $1.49 M(-8.1%) |
Dec 2017 | $1.62 M(-39.1%) | $450.00 K(-24.6%) | $1.62 M(+33.0%) |
Sept 2017 | - | $597.00 K(+303.4%) | $1.22 M(+95.8%) |
June 2017 | - | $148.00 K(-65.3%) | $623.00 K(+31.2%) |
Mar 2017 | - | $427.00 K(+789.6%) | $475.00 K(+889.6%) |
Dec 2016 | $2.66 M | $48.00 K | $48.00 K |
FAQ
- What is the all time high annual CAPEX for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Akebia Therapeutics?
- What is Akebia Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Akebia Therapeutics?
What is the all time high annual CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high annual capital expenditures is $6.66 M
What is Akebia Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of AKBA is $2000.00
What is the all time high quarterly CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly capital expenditures is $2.53 M
What is Akebia Therapeutics TTM capital expenditures?
The current TTM CAPEX of AKBA is $31.00 K
What is the all time high TTM CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM capital expenditures is $7.26 M